Ethema Health Corporation (GRST)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.71 Million USD | 15.09% |
| 2022 | 15.39 Million USD | -3.83% |
| 2021 | 16 Million USD | -13.22% |
| 2020 | 18.44 Million USD | -20.59% |
| 2019 | 23.23 Million USD | 13.96% |
| 2018 | 20.38 Million USD | 45.15% |
| 2017 | 14.04 Million USD | 286.13% |
| 2016 | 3.63 Million USD | 0.88% |
| 2015 | 3.6 Million USD | -6.75% |
| 2014 | 3.86 Million USD | -10.05% |
| 2013 | 4.29 Million USD | -5.78% |
| 2012 | 4.56 Million USD | 17.67% |
| 2011 | 3.87 Million USD | 237.4% |
| 2010 | 1.14 Million USD | 541.61% |
| 2009 | 179.08 Thousand USD | 32.98% |
| 2008 | 134.66 Thousand USD | 36.72% |
| 2007 | 98.5 Thousand USD | 35.86% |
| 2006 | 72.5 Thousand USD | 5.84% |
| 2005 | 68.5 Thousand USD | 6.2% |
| 2004 | 64.5 Thousand USD | 975.0% |
| 2003 | 6000.00 USD | 0.0% |
| 2001 | 540 Thousand USD | 22.73% |
| 2000 | 440 Thousand USD | -80.0% |
| 1999 | 2.2 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 18.13 Million USD | 2.34% |
| 2024 Q2 | 20.48 Million USD | 12.99% |
| 2023 Q2 | 11.72 Million USD | -26.91% |
| 2023 Q1 | 16.03 Million USD | 4.18% |
| 2023 Q3 | 17.51 Million USD | 49.42% |
| 2023 FY | 17.71 Million USD | 15.09% |
| 2023 Q4 | 17.71 Million USD | 1.17% |
| 2022 FY | 15.39 Million USD | -3.83% |
| 2022 Q3 | 16.14 Million USD | -0.75% |
| 2022 Q2 | 16.27 Million USD | 1.59% |
| 2022 Q1 | 16.01 Million USD | 0.04% |
| 2022 Q4 | 15.39 Million USD | -4.66% |
| 2021 FY | 16 Million USD | -13.22% |
| 2021 Q4 | 16 Million USD | -12.32% |
| 2021 Q1 | 18.51 Million USD | 0.38% |
| 2021 Q2 | 19.1 Million USD | 3.17% |
| 2021 Q3 | 18.25 Million USD | -4.43% |
| 2020 Q2 | 22.74 Million USD | -30.33% |
| 2020 Q1 | 32.64 Million USD | 40.51% |
| 2020 Q4 | 18.44 Million USD | -44.43% |
| 2020 FY | 18.44 Million USD | -20.59% |
| 2020 Q3 | 33.2 Million USD | 45.99% |
| 2019 Q1 | 38.16 Million USD | 87.2% |
| 2019 FY | 23.23 Million USD | 13.96% |
| 2019 Q2 | 33.71 Million USD | -11.66% |
| 2019 Q3 | 33.42 Million USD | -0.84% |
| 2019 Q4 | 23.23 Million USD | -30.5% |
| 2018 Q2 | 17.5 Million USD | 17.25% |
| 2018 Q3 | 19.38 Million USD | 10.71% |
| 2018 FY | 20.38 Million USD | 45.15% |
| 2018 Q4 | 20.38 Million USD | 5.17% |
| 2018 Q1 | 14.93 Million USD | 6.33% |
| 2017 FY | 14.04 Million USD | 286.13% |
| 2017 Q4 | 14.04 Million USD | 38.67% |
| 2017 Q3 | 10.12 Million USD | 1.92% |
| 2017 Q2 | 9.93 Million USD | 3.91% |
| 2017 Q1 | 9.56 Million USD | 162.93% |
| 2016 Q2 | 3.86 Million USD | 0.79% |
| 2016 Q3 | 3.45 Million USD | -10.62% |
| 2016 Q4 | 3.63 Million USD | 5.33% |
| 2016 FY | 3.63 Million USD | 0.88% |
| 2016 Q1 | 3.83 Million USD | 6.31% |
| 2015 Q4 | 3.6 Million USD | 10.15% |
| 2015 Q1 | 3.73 Million USD | -3.47% |
| 2015 FY | 3.6 Million USD | -6.75% |
| 2015 Q3 | 3.27 Million USD | -8.74% |
| 2015 Q2 | 3.58 Million USD | -3.9% |
| 2014 FY | 3.86 Million USD | -10.05% |
| 2014 Q1 | 4.03 Million USD | -6.02% |
| 2014 Q2 | 4.06 Million USD | 0.56% |
| 2014 Q4 | 3.86 Million USD | -0.27% |
| 2014 Q3 | 3.87 Million USD | -4.56% |
| 2013 Q4 | 4.29 Million USD | 0.77% |
| 2013 Q1 | 4.44 Million USD | -2.58% |
| 2013 Q2 | 4.14 Million USD | -6.81% |
| 2013 Q3 | 4.26 Million USD | 2.99% |
| 2013 FY | 4.29 Million USD | -5.78% |
| 2012 FY | 4.56 Million USD | 17.67% |
| 2012 Q4 | 4.56 Million USD | 0.58% |
| 2012 Q3 | 4.53 Million USD | 11.64% |
| 2012 Q2 | 4.06 Million USD | -7.47% |
| 2012 Q1 | 4.39 Million USD | 13.25% |
| 2011 Q1 | 1.64 Million USD | 43.34% |
| 2011 FY | 3.87 Million USD | 237.4% |
| 2011 Q4 | 3.87 Million USD | 28.1% |
| 2011 Q3 | 3.02 Million USD | 7.35% |
| 2011 Q2 | 2.81 Million USD | 71.17% |
| 2010 Q4 | 1.14 Million USD | 41.37% |
| 2010 FY | 1.14 Million USD | 541.61% |
| 2010 Q1 | 186.35 Thousand USD | 4.05% |
| 2010 Q2 | 470.55 Thousand USD | 152.51% |
| 2010 Q3 | 812.78 Thousand USD | 72.73% |
| 2009 Q1 | 136.56 Thousand USD | 1.41% |
| 2009 Q2 | 147.98 Thousand USD | 8.36% |
| 2009 Q3 | 159.53 Thousand USD | 7.8% |
| 2009 Q4 | 179.08 Thousand USD | 12.26% |
| 2009 FY | 179.08 Thousand USD | 32.98% |
| 2008 Q1 | 108.5 Thousand USD | 10.15% |
| 2008 Q4 | 134.66 Thousand USD | -11.91% |
| 2008 Q3 | 152.87 Thousand USD | 6.16% |
| 2008 Q2 | 144.01 Thousand USD | 32.73% |
| 2008 FY | 134.66 Thousand USD | 36.72% |
| 2007 Q3 | 93.5 Thousand USD | 19.11% |
| 2007 Q4 | 98.5 Thousand USD | 5.35% |
| 2007 FY | 98.5 Thousand USD | 35.86% |
| 2007 Q2 | 78.5 Thousand USD | 6.8% |
| 2007 Q1 | 73.5 Thousand USD | 1.38% |
| 2006 Q2 | 70.5 Thousand USD | 1.44% |
| 2006 FY | 72.5 Thousand USD | 5.84% |
| 2006 Q4 | 72.5 Thousand USD | 1.4% |
| 2006 Q1 | 69.5 Thousand USD | 1.46% |
| 2006 Q3 | 71.5 Thousand USD | 1.42% |
| 2005 FY | 68.5 Thousand USD | 6.2% |
| 2005 Q2 | 66.8 Thousand USD | 1.86% |
| 2005 Q4 | 68.5 Thousand USD | 0.0% |
| 2005 Q1 | 65.58 Thousand USD | 1.68% |
| 2004 FY | 64.5 Thousand USD | 975.0% |
| 2004 Q4 | 64.5 Thousand USD | 0.0% |
| 2004 Q1 | 23.45 Thousand USD | 290.92% |
| 2004 Q3 | 64.5 Thousand USD | 0.0% |
| 2003 FY | 6000.00 USD | 0.0% |
| 2003 Q4 | 6000.00 USD | 0.0% |
| 2001 Q4 | 540 Thousand USD | -81.76% |
| 2001 Q3 | 2.96 Million USD | 722.22% |
| 2001 Q2 | 360 Thousand USD | -37.93% |
| 2001 Q1 | 580 Thousand USD | 31.82% |
| 2001 FY | 540 Thousand USD | 22.73% |
| 2000 Q4 | 440 Thousand USD | -76.84% |
| 2000 FY | 440 Thousand USD | -80.0% |
| 2000 Q3 | 1.9 Million USD | 0.0% |
| 1999 FY | 2.2 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| The Amacore Group, Inc. | 24.7 Million USD | 28.289% |
| Arem Pacific Corporation | 304.9 Thousand USD | -5711.506% |
| Assisted 4 Living, Inc. | 184.16 Thousand USD | -9521.407% |
| BioCorRx Inc. | 10.34 Million USD | -71.345% |
| Bionik Laboratories Corp. | 5 Million USD | -254.197% |
| Banyan Corp. | 4.51 Million USD | -292.159% |
| Clearday, Inc. | 65.13 Million USD | 72.795% |
| Dental Patient Care America, Inc. | 1.8 Million USD | -883.267% |
| Quantum Medical Transport, Inc. | 1504.02 USD | -1178039.652% |
| Empower Clinics Inc. | 9.18 Million USD | -92.902% |
| First Choice Healthcare Solutions, Inc. | 31.65 Million USD | 44.02% |
| Selectis Health, Inc. | 43.63 Million USD | 59.392% |
| HealthLynked Corp. | 3.47 Million USD | -409.852% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.47 Million USD | -22.416% |
| JRSIS Health Care Corporation | 2.3 Million USD | -668.681% |
| Comjoyful International Company | 6.32 Million USD | -180.101% |
| Medical Facilities Corporation | 235.37 Million USD | 92.472% |
| MedSmart Group Inc. | 927.53 Thousand USD | -1810.39% |
| North America Frac Sand, Inc. | 936.85 Thousand USD | -1791.387% |
| Nova Leap Health Corp. | 2.69 Million USD | -556.53% |
| Nexteligent Holdings, Inc. | 2.88 Million USD | -514.804% |
| PAO Group, Inc. | 1.04 Million USD | -1593.111% |
| Primemd Inc. | 7.98 Million USD | -121.807% |
| Raffles Medical Group Ltd | 367.04 Million USD | 95.172% |
| Ryman Healthcare Limited | 5.17 Billion USD | 99.658% |
| Stem Cell Authority, Ltd. | 80.52 Thousand USD | -21904.913% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 3.91 Million USD | -352.51% |
| Mycotopia Therapies, Inc. | 4.24 Million USD | -317.152% |
| U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | -2521.221% |
| Veltex Corporation | 2.87 Million USD | -515.85% |
| World Financial Holding Group | 132.5 Thousand USD | -13272.67% |
| Xcelerate Inc. | 2.07 Million USD | -753.715% |